The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI116201PMID 7678610PMCID PMC329995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of the contact system in lethal hypotensive bacteremia in a baboon model.

  1992cited by this paper
• Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

  1991cited by this paper
• C4b-binding protein exacerbates the host response to Escherichia coli.

  1991cited by this paper
• Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli.

  1991cited by this paper
• Alpha 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis.

  1991cited by this paper
• DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.

  1991cited by this paper
• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  1991cited by this paper
• Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).

  1990cited by this paper
• Proteolytic inactivation of plasma C1- inhibitor in sepsis.

  1989cited by this paper
• A simple and accurate microplate assay for the determination of factor XI in plasma.

  1988cited by this paper
• Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.

  1988cited by this paper
• Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

  1987cited by this paper
• Evaluation of a microassay for human plasma prekallikrein.

  1987cited by this paper
• Purification of human factor XII from plasma using zinc chelate affinity chromatography.

  1986cited by this paper
• Using and Understanding Medical Statistics

  1985cited by this paper
• The regulation of human factor XIIa by plasma proteinase inhibitors.

  1985cited by this paper
• Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes.

  1985cited by this paper
• A rapid method for removal of [125I]iodide following iodination of protein solutions.

  1980cited by this paper
• Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.

  1979cited by this paper
• Plasma kallikrein activation and inhibition during typhoid fever.

  1978cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper
• Biostatistics in medicine.

  1977cited by this paper
• Kinin activation in the blood of patients with sepsis.

  1976cited by this paper
• Plasma kallikrein and Hageman factor in Gram-negative bacteremia.

  1970cited by this paper
• The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

  1961cited by this paper
• THE ASSAY AND PROPERTIES OF LABILE FACTOR (FACTOR V)

  1960cited by this paper
• Distribution of Plasma Kallikrein between C i Inactivator and cy 2-Macroglobulin in Plasma Utilizing a New Assay for a 2-Macroglobulin-Kallikrein Complexes *

  year unknowncited by this paper

• A central role of factor XI in a baboon model of Staphylococcus aureus sepsis.

  2025cites this paper
• Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation.

  2025cites this paper
• Factor XII–driven coagulation traps bacterial infections

  2025cites this paper
• Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate

  2024cites this paper
• A hypothesis linking the renin-angiotensin, kallikrein-kinin systems, and disseminated coagulation in covid-19

  2024cites this paper
• Steps Toward Recapitulating Endothelium: A Perspective on the Next Generation of Hemocompatible Coatings.

  2024cites this paper
• Targeting factor XIIa for therapeutic interference with hereditary angioedema

  2024cites this paper
• Venous thromboembolism in viral diseases: A comprehensive literature review

  2023cites this paper
• Pathophysiology of bradykinin and histamine mediated angioedema

  2023cites this paper
• Temporal Trends, Predictors, and Outcomes of Disseminated Intravascular Coagulation in Hospitalizations With Sepsis

  2022cites this paper
• Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa.

  2022cites this paper
• Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus

  2021cites this paper
• An update on factor XII-driven vascular inflammation.

  2021cites this paper
• The versatile role of the contact system in cardiovascular disease, inflammation, sepsis and cancer.

  2021cites this paper
• Factor XII(a) inhibitors: a review of the patent literature

  2021cites this paper
• Disseminated intravascular coagulation following femoral nailing in a metastatic prostate carcinoma patient – A case report

  2021cites this paper
• Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H

  2021cites this paper
• The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

  2020cites this paper
• Factor XII/XIIa inhibitors: Their discovery, development, and potential indications.

  2020cites this paper
• The contact activation system as a potential therapeutic target in patients with COVID‐19

  2020cites this paper
• Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates

  2020cites this paper
• The synthetic LPS binding peptide 19-2.5 interferes with clotting and prevents degradation of high molecular weight kininogen in plasma

  2020cites this paper
• Kinins and Their Receptors in Infectious Diseases

  2020cites this paper
• Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses

  2020cites this paper
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

  2020cites this paper
• Inhibition of contact-mediated activation of factor XI protects baboons against S aureus-induced organ damage and death.

  2019cites this paper
• The contact pathway and sepsis

  2019cites this paper
• Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.

  2019cites this paper
• Prekallikrein inhibits innate immune signaling in the lung and impairs host defense during pneumosepsis in mice

  2019cites this paper
• Roles of Factor XII in Innate Immunity

  2019influential citation
• Factor XII – What's important but not commonly thought about

  2019cites this paper
• The coagulation system in host defense

  2018cites this paper
• Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways.

  2018cites this paper
• Factor XII in coagulation, inflammation and beyond.

  2018cites this paper
• Early depletion of contact system in patients with sepsis: a prospective matched control observational study

  2018cites this paper
• Limited role of kininogen in the host response during gram-negative pneumonia-derived sepsis.

  2018cites this paper
• Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia-derived sepsis.

  2018cites this paper
• Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI

  2018cites this paper
• Factor XII truncation accelerates activation in solution

  2018cites this paper
• Effets anti-inflammatoires de l'inhibiteur dépendant de la protéine Z : intérêt potentiel comme traitement adjuvant du sepsis. (Anti-inflammatory effects of Protein Z-dependent protease inhibitor (ZPI) : potential benefit on sepsis adjuvant therapy)

  2018cites this paper
• Coagulation factor XII regulates inflammatory responses in human lungs

  2017cites this paper
• Immunohaemostasis: a new view on haemostasis during sepsis

  2017cites this paper
• C 1 esterase inhibitor mediated protection from acute lung injury

  2017cites this paper
• Contact system activation and high thrombin generation in hyperthyroidism.

  2017cites this paper
• The initiation and effects of plasma contact activation: an overview

  2017cites this paper
• The plasma contact system, a protease cascade at the nexus of inflammation, coagulation and immunity.

  2017cites this paper
• Factor VII-Activating Protease: Hemostatic Protein or Immune Regulator?

  2017cites this paper
• Aeromonas sobria serine protease (ASP): a subtilisin family endopeptidase with multiple virulence activities

  2017cites this paper
• The role of contact system in septic shock: the next target? An overview of the current evidence

  2017cites this paper
• Contact-Activation Pathways as Targets for New Anticoagulants

  2016cites this paper
• Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coagulation.

  2016cites this paper
• Processing of Factor XII during Inflammatory Reactions

  2016cites this paper
• Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in Mice

  2016influential citation
• Study of acute hemocoagulation changes in a porcine endotoxemic shock model using thrombelastography.

  2015cites this paper
• Factor XII: a novel target for safe prevention of thrombosis and inflammation

  2015cites this paper
• New agents for thromboprotection

  2015cites this paper
• Factor XII: a drug target for safe interference with thrombosis and inflammation.

  2014cites this paper
• Factor XII inhibition reduces thrombus formation in a primate thrombosis model.

  2014cites this paper
• Thrombocytopenia-Associated Multiple Organ Failure Syndrome

  2014cites this paper
• A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk

  2014cites this paper
• The role of the contact pathway in thrombus propagation.

  2014cites this paper
• Staphopains in Staphylococcus aureus bacteremia: Virulence activities related to the onset of septic shock, coagulation disorders, and infectious endocarditis

  2014cites this paper
• Crosstalk between the coagulation and complement systems in sepsis.

  2014cites this paper
• Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder

  2014cites this paper
• Is the neutrophil a ‘prima donna’ in the procoagulant process during sepsis?

  2014cites this paper
• Tracking down contact activation – from coagulation in vitro to inflammation in vivo

  2014cites this paper
• A Short Contemporary History of Disseminated Intravascular Coagulation

  2014cites this paper
• Bacteria under stress by complement and coagulation.

  2014cites this paper
• Dynamic regulation of neutrophil activation, migration and death

  2013cites this paper
• 12 – Disseminated Intravascular Coagulation

  2013cites this paper
• Cysteine Proteinase from Streptococcus pyogenes Enables Evasion of Innate Immunity via Degradation of Complement Factors*

  2013cites this paper
• Quel avenir pour les médicaments de l’hémostase dans le traitement du sepsis sévère après le Xigris® ?

  2013cites this paper
• Identifying functional single nucleotide polymorphisms in two candidate genes (PROC and PCSK9) in sepsis

  2013cites this paper
• Einfluss von C1-Esterase Inhibitor in Kombination mit Blutgerinungsfaktor XIII auf die mesenteriale Mikrozirkulation bei experimenteller Endotoxinämie

  2013cites this paper
• Hereditary angioedema: a bradykinin-mediated swelling disorder

  2013cites this paper
• Crosstalk of the plasma contact system with bacteria.

  2012cites this paper
• PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.

  2012cites this paper
• FSAP, a new player in inflammation?

  2012cites this paper
• Regulatory mechanisms of the plasma contact system.

  2012cites this paper
• Making contact with microparticles

  2012cites this paper
• Thrombus formation and innate immunity

  2012cites this paper
• İnflamasyonda trombositlerin rolü

  2012cites this paper
• Effect of Preoperative Biliary Drainage on Coagulation and Fibrinolysis in Severe Obstructive Cholestasis

  2012cites this paper
• Bacterial Abuse of Mammalian Extracellular Proteases during Tissue Invasion and Infection

  2012cites this paper
• Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.

  2012cites this paper
• Exposición simultánea y secuencial al lipopolisacárido de Pasteurella multocida y a la bacteria en cultivos de fosa nasal de conejo

  2012cites this paper
• C1-Inhibitor: More Than a Serine Protease Inhibitor

  2011cites this paper
• Factor XI-Deficient Mice Display Reduced Inflammation, Coagulopathy, and Bacterial Growth during Listeriosis

  2011cites this paper
• Intestinal tissue kallikrein-kinin system in inflammatory bowel disease.

  2011cites this paper
• Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes

  2011cites this paper
• Animal models of DIC and their relevance to human DIC: a systematic review.

  2011cites this paper
• Coagulation biomarkers in critically ill patients.

  2011cites this paper
• Innate immunity and coagulation

  2011cites this paper
• El Lipopolisacárido 1

  2010cites this paper
• Gerinnung bei schwerer Sepsis unter besonderer Berücksichtigung der Monozyten

  2010cites this paper
• Effect of Preoperative Biliary Drainage on Coagulation and Fibrinolysis in Severe Obstructive Cholestasis

  2010cites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Sepsis-associated Dissemin Thromboembolic Disease Associated Disseminated Intravascular Coagulation a Coagulation And

  2010cites this paper
• Contact system activation in severe infectious diseases

  2010cites this paper
• Tissue factor and thrombosis: The clot starts here

  2010cites this paper
• Shock: An Update

  2010cites this paper